Obesity is a complex illness which requires an understanding of multiple treatment modalities. We are committed to reduce the stigma around obesity. In this unique and world-leading MSc, you explore ...

Obesity dipped slightly in U.S. adults last year for the first time in more than a decade, a study found. The researchers suggested that might be due, in part, to the rise of weight loss drugs ...

U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose By Ernie Mundell HealthDay Reporter FRIDAY, Dec. 13, 2024 (HealthDay News) -- The U.S. obesity rate declined for the first time in a ...

The study reviewed the body mass index (BMIs), a measure of obesity, of 16.7 million U.S. adults over a 10-year period. The average BMI rose annually to 30.24 -- which is considered obese -- until ...

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds. Data on almost 17 million adults nationwide showed ...

Data on almost 17 million adults nationwide showed the obesity rate -- which has been rising for years -- fell from 46.2% of adults in 2021 to 45.6% in 2023, Harvard University researchers report.

In 2023, the United States saw a slight decrease in obesity prevalence among adults, according to research findings published Dec. 13 in JAMA. Amid projections of increasing obesity rates over the ...

For the first time in a decade, the obesity rate for adult Americans charted a slight decline in 2023 The trend follows the rising use of GLP-1 weight-loss medications such as Zepbound or Wegovy ...